State of treatment of coronary artery disease by drug releasing stents;Aktueller stand der therapie der koronaren herzkrankheit mit medikamentenbeschichteten stents

Herz

Volumn 27, Issue 6, 2002, Pages 508-513

  Müller, Ralf ^a   Büllesfeld, Lutz ^a   Gerckens, Ulrich ^a   Grube, Eberhard ^a  

^a Heart Center Siegburg   (Germany)

Author keywords

Coronary heart disease; PTCA; Restenosis; Stent

Indexed keywords

ANTIINFLAMMATORY AGENT; CILOSTAZOL; CLOPIDOGREL; DACTINOMYCIN; DEXAMETHASONE; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; TACROLIMUS;

CONTROLLED DRUG RELEASE; CORONARY ARTERY DISEASE; CORONARY STENT; DOSE RESPONSE; DRUG COATING; HEART CATHETER; HUMAN; RESTENOSIS; REVASCULARIZATION; REVIEW; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-INFLAMMATORY AGENTS; CELL DIVISION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY DISEASE; DRUG CARRIERS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RANDOMIZED CONTROLLED TRIALS; STENTS; TREATMENT OUTCOME;

EID: 0036746055     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-002-2426-z     Document Type: Review

References (18)

1. De Scheerder I, Huang Y, Dens J, et al. Treatment of in-stent restenosis using paclitaxel eluting stents: a single centre pilot trial. Circulation 2001;104:11-742.
2. Drachman DE, Edelmann ER, Seifert P, et al. Neointimal thickening after stent delivery of paclitaxel: changes incomposition and arrest of growth over six months. J Am Coll Cardiol 2000;36:2325-32.
3. Gershlick AH, Descheerder I, Chevalier B. Local drug delivery to inhibit coronary artery restenosis. Data from the ELUTES (EvaLUation of pacliTaxel Eluting Stent). Circulation 2001;104:11-416.
4. Grube E, Gerckens U, Rowold S, et al. Inhibition of in-stent restenosis by the Quanam drug eluting polymer stent; two year follow-up. J Am Cardiol 2001;37:74A.
5. Grube E, Lansky AJ, Reifart N, et al. SCORE 6-mo angiogaphic results: Improved restenosis in patients receiving the QUADDS-QP2 drug-eluting stent compared with the control bare stent. J Am Coll Cardiol 2002;39:59A.
6. Grube E, Gerckens U, Rowold S, et al. Inhibition of in-stent restenosis by a drug eluting polymer stent: pilot trial with 18 month follow-up. Circulation 2000;102:II-554A.
7. Grube E, Gerckens U, Müller R, et al. Drug eluting stents: initial experiences. Z Kardiol (in press).
8. Honda J, Grube E, de la Fuenta LM, et al. Novel drug-delivery stent. Intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system. Circulation 2001;104:380-3.
9. Lansky AJ, Reifart N, Fajadet J, et al. Effects of the QUAAS-QP2 drug-eluting stent extends beyond the targeted area into adjacent non-stented zones: Results of the SCORE trial. J Am Coll Cardiol 2002;39:26A.
10. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
11. Müller R, Gerckens U, Hauptmann KE, et al. Die TAXUS I Studie mit dem Paclitaxel beschichteten NIRx™ Stent-angiographische Ergebnisse und klinisches follow-up. Z Kardiol 2002:91;1-65A.
12. Park SJ, Shim WH, Ho DS, et al. The clinical effectiveness of Paclitaxel-coated coronary stents for the reduction of restenosis in the ASPECT-trial. Circulation 2001;104:11-464.
13. Rensing BJ, Vos J, Smits PC, et al. Coronary restenosis elimination with a sirolimus eluting stent. First European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 2001;22:2125-30.
14. Silber S. Antiproliferativ beschichtete Stents und intrakoronare Brachytherapie: Gemeinsamkeiten und Unterschiede. Z Kardiol 2002;91:443-57.
15. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries. Circulation 2001;103:192-5.
16. Sousa JE, Costa MA, Abizaid A, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents. One-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-11.
17. Tanabe K, Serruys PW, Grube E, et al. TAXUS III Trial: In-stent restenosis treated with stent based delivery of paclitaxel control-released through polymer. Circulation (in press).
18. Waksman R, Rodriquez JC, Robinson KA. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1997;97:1944-52.